X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16814) 16814
Publication (1437) 1437
Book Review (269) 269
Magazine Article (116) 116
Book / eBook (60) 60
Book Chapter (23) 23
Conference Proceeding (19) 19
Dissertation (8) 8
Web Resource (4) 4
Data Set (3) 3
Government Document (2) 2
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12499) 12499
male (9504) 9504
female (7023) 7023
index medicus (6250) 6250
antidepressive agents - therapeutic use (5812) 5812
psychiatry (5387) 5387
animals (5360) 5360
adult (5117) 5117
pharmacology & pharmacy (4374) 4374
antidepressants (4364) 4364
antidepressive agents - administration & dosage (4278) 4278
middle aged (4155) 4155
depression (3700) 3700
antidepressive agents - pharmacology (3566) 3566
neurosciences (3133) 3133
rats (2970) 2970
treatment outcome (2836) 2836
depression - drug therapy (2769) 2769
depressive disorder - drug therapy (2740) 2740
aged (2599) 2599
antidepressive agents - adverse effects (2416) 2416
dose-response relationship, drug (2142) 2142
depressive disorder, major - drug therapy (1951) 1951
mice (1935) 1935
major depression (1861) 1861
adolescent (1789) 1789
depression, mental (1736) 1736
clinical neurology (1658) 1658
drug therapy, combination (1551) 1551
time factors (1480) 1480
double-blind (1472) 1472
antidepressant (1465) 1465
drug administration schedule (1451) 1451
fluoxetine (1365) 1365
drug therapy (1313) 1313
major depressive disorder (1286) 1286
double-blind method (1277) 1277
antidepressive agents, second-generation - therapeutic use (1226) 1226
antidepressive agents, tricyclic - administration & dosage (1198) 1198
disease models, animal (1182) 1182
antidepressive agents, tricyclic - therapeutic use (1153) 1153
antidepressive agents, second-generation - administration & dosage (1138) 1138
research (1136) 1136
psychiatric status rating scales (1131) 1131
serotonin (1087) 1087
behavior, animal - drug effects (1082) 1082
dosage and administration (1059) 1059
serotonin uptake inhibitors - therapeutic use (1056) 1056
rats, sprague-dawley (1014) 1014
care and treatment (999) 999
mental depression (996) 996
analysis (965) 965
depressive disorder - psychology (962) 962
risk factors (962) 962
motor activity - drug effects (941) 941
drug interactions (930) 930
brain (922) 922
rats, wistar (908) 908
medicine, general & internal (907) 907
antidepressive agents, second-generation - adverse effects (876) 876
young adult (855) 855
anxiety (854) 854
antidepressive agents, tricyclic - pharmacology (832) 832
serotonin reuptake inhibitors (827) 827
efficacy (816) 816
drugs (814) 814
brain - drug effects (793) 793
child (763) 763
health aspects (752) 752
serotonin uptake inhibitors - administration & dosage (720) 720
brain - metabolism (713) 713
article (712) 712
imipramine (706) 706
serotonin uptake inhibitors - adverse effects (699) 699
antidepressive agents, tricyclic - adverse effects (674) 674
united states (674) 674
hippocampus - drug effects (671) 671
antipsychotic agents - therapeutic use (661) 661
swimming (644) 644
bipolar disorder - drug therapy (639) 639
administration, oral (638) 638
forced swimming test (633) 633
aged, 80 and over (605) 605
psychology, clinical (598) 598
antidepressive agents (592) 592
stress (592) 592
fluoxetine - pharmacology (582) 582
prevalence (578) 578
psychotherapy (572) 572
follow-up studies (571) 571
antidepressive agents, second-generation - pharmacology (570) 570
placebo-controlled trial (570) 570
serotonin - metabolism (570) 570
imipramine - pharmacology (567) 567
comorbidity (563) 563
venlafaxine hydrochloride (561) 561
depressive disorder - diagnosis (554) 554
severity of illness index (553) 553
paroxetine (548) 548
depressive disorder, major - psychology (546) 546
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (49) 49
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Online Resources - Online (4) 4
UTL at Downsview - May be requested (4) 4
UofT at Mississauga - Stacks (3) 3
Robarts - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Scarborough - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15467) 15467
German (361) 361
French (289) 289
Russian (232) 232
Japanese (129) 129
Spanish (75) 75
Polish (66) 66
Norwegian (65) 65
Swedish (65) 65
Chinese (41) 41
Italian (41) 41
Danish (40) 40
Hungarian (40) 40
Dutch (28) 28
Portuguese (13) 13
Turkish (12) 12
Finnish (11) 11
Czech (10) 10
Bulgarian (6) 6
Hebrew (6) 6
Lithuanian (4) 4
Ukrainian (4) 4
Serbian (2) 2
Afrikaans (1) 1
Greek (1) 1
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Summary Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other... 
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | CHRONIC HEPATITIS-C | GASTROENTEROLOGY & HEPATOLOGY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2014, Volume 32, Issue 18, pp. 1941 - 1967
Purpose To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies... 
ACUTE PAIN SYNDROME | PROSPECTIVE SURVEILLANCE MODEL | ONCOLOGY | DOUBLE-BLIND | REDUCED GLUTATHIONE | QUALITY-OF-LIFE | CISPLATIN-INDUCED TOXICITIES | VITAMIN-E SUPPLEMENTATION | PLACEBO-CONTROLLED TRIAL | OXALIPLATIN-RELATED NEUROTOXICITY | ADVANCED COLORECTAL-CANCER | Thiophenes - therapeutic use | Peripheral Nervous System Diseases - chemically induced | United States | Humans | Peripheral Nervous System Diseases - physiopathology | Antineoplastic Agents - administration & dosage | Ketamine - administration & dosage | Incidence | Neuralgia - prevention & control | Peripheral Nervous System Diseases - prevention & control | Antineoplastic Agents - adverse effects | Amines - therapeutic use | Neuralgia - etiology | Adult | gamma-Aminobutyric Acid - therapeutic use | Drug Therapy, Combination | Peripheral Nervous System Diseases - complications | Severity of Illness Index | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Gels | Baclofen - administration & dosage | Comorbidity | Survivors | Anticonvulsants - therapeutic use | Treatment Outcome | Evidence-Based Medicine | Neuralgia - drug therapy | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Antidepressive Agents, Tricyclic - therapeutic use | Duloxetine Hydrochloride | Quality of Life | Peripheral Nervous System Diseases - drug therapy | Amitriptyline - administration & dosage
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 07/2006, Volume 11, Issue 7, pp. 680 - 684
Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E-2 ( PGE(2)), have repeatedly been... 
COX-2 inhibition | Inflammation | Psychoneuroimmunology | Major depression | Immunity | SYSTEM | COX-2 | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | psychoneuroimmunology | SCHIZOPHRENIA | SICKNESS BEHAVIOR | SYMPTOMS | immunity | NEUROSCIENCES | INFLAMMATORY MARKERS | INTERFERON-ALPHA | PROSTAGLANDINS | inflammation | ROFECOXIB | major depression | BRAIN | Anti-Anxiety Agents - administration & dosage | Dinoprostone - analysis | Pyrazoles - therapeutic use | Adrenergic Uptake Inhibitors | Dinoprostone - biosynthesis | Humans | Middle Aged | Depressive Disorder - drug therapy | Male | Patient Dropouts | Lorazepam - therapeutic use | Inflammation - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Female | Antidepressive Agents - pharmacology | Anti-Anxiety Agents - therapeutic use | Drug Therapy, Combination | Morpholines - therapeutic use | Pyrazoles - pharmacology | Severity of Illness Index | Cyclooxygenase 2 Inhibitors - pharmacology | Double-Blind Method | Cyclooxygenase 2 Inhibitors - administration & dosage | Morpholines - administration & dosage | Lorazepam - administration & dosage | Celecoxib | Sulfonamides - pharmacology | Antidepressive Agents - therapeutic use | Pilot Projects | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Depressive Disorder - physiopathology | Serotonin - metabolism | Interleukin-6 - biosynthesis | Antidepressive Agents - administration & dosage | Psychological Tests | Sulfonamides - administration & dosage | Inflammation - physiopathology
Journal Article
The World Journal of Biological Psychiatry, ISSN 1562-2975, 04/2013, Volume 14, Issue 3, pp. 154 - 219
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
Journal Article
Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Journal Article